Tenaya Therapeutics, Inc. (TNYA)
0.6946
+0.01
(+2.00%)
USD |
NASDAQ |
Apr 02, 16:00
0.6951
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics EPS Diluted (Quarterly) : -0.1152 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Marker Therapeutics, Inc. | -0.1022 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Protagonist Therapeutics, Inc. | -0.6932 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.18M |
| Total Expenses (Quarterly) | 20.18M |
| Enterprise Value | 61.01M |
| Earnings Yield | -88.41% |
| Normalized Earnings Yield | -88.42 |